Skip to main content

Table 4 Direct cost to the providers due to human antibiotic consumption in each resistant infection

From: Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use

 

Thailand

United States

S. aureus

E. coli

K. pneumoniae

A. baumanii

P. aeruginosa

S. aureus

E. coli

K. pneumoniae

A. baumanii

P. aeruginosa

Total infections

18,725

11,116

15,239

36,553

6118

80,461

10,400

24,900

7300

6700

Cost per infection

1551

956

956

1749

1601

1415

1415

1415

1415

1415

Direct cost (million US$)

29.0

10.6

14.6

63.9

9.8

113.8

14.7

35.2

10.3

9.5

RMf

0.37

0.27

0.35

0.45

0.52

0.37

0.27

0.35

0.45

0.52

Direct cost due to human consumption (million US$)

10.7

2.9

5.1

28.8

5.1

42.1

4.0

12.3

4.6

4.9